Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
NL0012044747
Mon, 06.03.2023
SHOP APOTHEKE EUROPE N.V.
SHOP APOTHEKE EUROPE N.V.: No prolongation of his term as CEO by Stefan Feltens
Sevenum, 6 March 2023 – SHOP APOTHEKE EUROPE N.V. (SAE.DE) hereby announces that its CEO, Stefan Feltens, will for personal reasons, after his current term of office not be available for a further term and will therefore retire from the managing board of the company at [ … ]
Mon, 06.03.2023
SHOP APOTHEKE EUROPE N.V.
SHOP APOTHEKE EUROPE N.V.: No prolongation of his term as CEO by Stefan Feltens
Sevenum, 6 March 2023 – SHOP APOTHEKE EUROPE N.V. (SAE.DE) hereby announces that its CEO, Stefan Feltens, will for personal reasons, after his current term of office not be available for a further term and will therefore retire from the managing board of the company at [ … ]
Tue, 12.04.2022
SHOP APOTHEKE EUROPE N.V.
SHOP APOTHEKE EUROPE: ACQUISITION OF "FIRST A", A PIONEERING QUICK-COMMERCE PLAYER IN THE GERMAN PHARMACY MARKET.
Strategic acquisition of one of Germany's pioneer in q-commerce that delivers pharmacy products door-to-door within 30 minutes.
Entry into the growing q-commerce market.
Complementing the launch of e-Rx through close partnerships wit [ … ]
Thu, 22.07.2021
SHOP APOTHEKE EUROPE N.V.
SHOP APOTHEKE EUROPE: change of forecast for the 2021 financial year
Sevenum, 22 July 2021. In the context of preparing the interim financial report for the first half of 2021, the Management Board of SHOP APOTHEKE EUROPE has analysed the company's financial development and as a result has come to a new assessment of the forecast for the 2021 fin [ … ]
Thu, 14.01.2021
SHOP APOTHEKE EUROPE N.V.
NOT FOR DIRECT OR INDIRECT PUBLICATION, DISTRIBUTION OR RELEASE IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY JURISDICTION IN WHICH OFFERS OR SALES OF THE SECURITIES WOULD BE PROHIBITED BY APPLICABLE LAWS.
SHOP APOTHEKE EUROPE N.V. increases size of the convertible bond offering due to high demand.
Venlo, January 1 [ … ]
Thu, 14.01.2021
SHOP APOTHEKE EUROPE N.V.
NOT FOR DIRECT OR INDIRECT PUBLICATION, DISTRIBUTION OR RELEASE IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY JURISDICTION IN WHICH OFFERS OR SALES OF THE SECURITIES WOULD BE PROHIBITED BY APPLICABLE LAWS.
SHOP APOTHEKE EUROPE N.V. launches EUR 200 million convertible bonds
Aggregate Principal Amount: EUR 200 mill [ … ]
Thu, 07.01.2021
SHOP APOTHEKE EUROPE N.V.
NOT FOR DIRECT OR INDIRECT PUBLICATION, DISTRIBUTION OR RELEASE IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA AND JAPAN OR ANY JURISDICTION IN WHICH OFFERS OR SALES OF THE SECURITIES WOULD BE PROHIBITED BY APPLICABLE LAW.
SHOP APOTHEKE EUROPE Acquires Digital Health Provider SMARTPATIENT.
Strategic acquisition of the Munich-based spe [ … ]
Wed, 14.10.2020
SHOP APOTHEKE EUROPE N.V.
NOT FOR DIRECT OR INDIRECT PUBLICATION, DISTRIBUTION OR RELEASE IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA AND JAPAN OR ANY JURISDICTION IN WHICH OFFERS OR SALES OF THE SECURITIES WOULD BE PROHIBITED BY APPLICABLE LAW.
SHOP APOTHEKE EUROPE N.V. ANNOUNCES REDEMPTION OF ITS EUR 135 MILLION 4.5% CONVERTIBLE BONDS DUE 2023.
Venlo, 1 [ … ]
Tue, 06.10.2020
SHOP APOTHEKE EUROPE N.V.
NOT FOR DIRECT OR INDIRECT PUBLICATION, DISTRIBUTION OR RELEASE IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA AND JAPAN OR ANY JURISDICTION IN WHICH OFFERS OR SALES OF THE SECURITIES WOULD BE PROHIBITED BY APPLICABLE LAW.
SHOP APOTHEKE EUROPE N.V. ENDS DISCUSSIONS AND ANNOUNCES CLEAN-UP OF ITS EUR 135 MILLION 4.5% CONVERTIBLE BONDS [ … ]
Wed, 30.09.2020
SHOP APOTHEKE EUROPE N.V.
NOT FOR DIRECT OR INDIRECT PUBLICATION, DISTRIBUTION OR RELEASE IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA AND JAPAN OR ANY JURISDICTION IN WHICH OFFERS OR SALES OF THE SECURITIES WOULD BE PROHIBITED BY APPLICABLE LAW.
SHOP APOTHEKE EUROPE N.V. ANNOUNCES UPDATE ON DISCUSSIONS ABOUT ITS EUR 135 MILLION 4.5% CONVERTIBLE BONDS DUE 2 [ … ]